Welcome to our dedicated page for JBT MAREL SEC filings (Ticker: JBTM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
JBT Marel Corporation filings document the company's food and beverage technology business, public-company governance and capital structure. Form 8-K reports furnish quarterly and full-year results, guidance materials, Regulation FD investor presentations, segment realignment disclosures and other material corporate events tied to its Protein Solutions and Prepared Food and Beverage Solutions operations.
The company's SEC record also includes proxy disclosures on board matters, executive compensation and annual meeting governance. Capital-structure filings describe common stock and convertible senior notes due 2030, including related indenture, hedge and warrant arrangements, while officer-transition disclosures record changes in financial reporting responsibilities.
JBT Marel Corporation, a global food and beverage technology provider, reported stronger results for the quarter and six months ended June 30, 2026. Second‑quarter revenue rose to $981 million, up 4.9% year over year, with growth in both recurring and project-related sales and a tailwind from foreign exchange. Gross margin improved to 36.6% from 35.8%, helped by tariff recoveries, higher volumes and better fixed‑cost leverage, partly offset by inflation.
Quarterly net income increased to $28 million (diluted EPS $0.54) versus $3 million a year earlier, while Adjusted EBITDA rose to $168 million with a 17.1% margin. For the first six months, revenue reached $1.917 billion, net income was $73 million versus a $170 million loss in 2025, and Adjusted EBITDA was $310 million with a 16.2% margin, driven by higher volume, lower acquisition‑ and pension‑related costs, and a sharp drop in interest expense.
Protein Solutions led growth, with Q2 revenue up 10.9% to $467 million and Adjusted EBITDA margin expanding to 24.0%. Prepared Food and Beverage Solutions revenue was flat at $514 million, with margin easing to 17.5% amid operational inefficiencies and inflation. Operating cash flow strengthened to $221 million for the half. Total debt was $1.679 billion at June 30, 2026, after repayment of $403 million of 2026 convertible notes. The company recorded a $33 million intangible impairment in Protein Solutions and has incurred $41 million of cumulative restructuring charges under its JBT Marel 2025 Integration plan, targeting $55–$60 million in total. Management highlights a record backlog and $1.5 billion of remaining performance obligations and continues to expect full‑year 2026 growth in revenue, margins and earnings per share.
JBT Marel Corporation reported solid second‑quarter 2026 results, with revenue of $981 million, up 5 percent, and orders above $1 billion, producing a 1.05x book‑to‑bill ratio. Net income was $28 million, a $25 million increase, for a 2.9 percent margin despite a $33 million non‑cash impairment charge related to a 2021 acquisition.
Adjusted EBITDA rose to $168 million with a 17.1 percent margin, and diluted EPS was $0.54 while adjusted EPS reached $1.95. The Protein Solutions segment grew revenue 11 percent with a 24.0 percent adjusted EBITDA margin, while Prepared Food and Beverage Solutions revenue was flat and margin slipped to 17.5 percent amid logistics constraints and productivity inefficiencies.
Year‑to‑date operating cash flow was $221 million and free cash flow $179 million. Net debt was $1,586 million, equating to 2.47x net debt to trailing twelve months adjusted EBITDA. The company repurchased about 200,000 shares for $26 million and reaffirmed full‑year 2026 guidance for $3,990–$4,065 million in revenue, 17.0–17.5 percent adjusted EBITDA margin, and adjusted EPS of $7.85–$8.35.
Moller Andrew James reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp reported that VP & Chief Accounting Officer Andrew James Moller received a grant of 743 shares of Common Stock in the form of restricted stock units.
The award was recorded at $0.0000 per share and will settle one-for-one in Common Stock on the first anniversary of the grant date, subject to his continued service. After this grant, he holds 743 shares directly.
JBT MAREL Corp executive James C. Pelletier, EVP & General Counsel, reported a routine tax-related share disposition. On this Form 4, 409 shares of Common Stock were delivered at $145.00 per share to satisfy tax obligations, classified as a tax-withholding disposition rather than an open-market sale.
Following this transaction, Pelletier directly holds 3,392 shares of JBT MAREL Corp Common Stock. The filing reflects a small, mechanical adjustment to his equity position tied to compensation-related taxes.
JBT MAREL Corp executive Andrew James Moller, who serves as VP & Chief Accounting Officer, has filed an initial Form 3 reporting his holdings in the company’s common stock. The filing shows he reports beneficial ownership of 0 shares of Common Stock as of 2026-06-01. This is a disclosure of his starting ownership position rather than a new stock purchase or sale.
JBT MAREL Corp director Ann Savage reported an equity award of 1,232 restricted stock units (RSUs), classified as an acquisition under a compensation grant. The RSUs will settle one-for-one into shares of Common Stock on June 1, 2027, subject to her continued service through that date.
Following this award, her directly held Common Stock position reported in the filing totals 2,987 shares. The transaction involved no open-market buying or selling and reflects routine, stock-based director compensation rather than a cash investment decision.
Masson Arnar Thor reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp director Masson Arnar Thor received a stock-based compensation award in the form of 1,232 restricted stock units (RSUs) of Common Stock. These RSUs were granted at no cash cost and will settle one-for-one into shares of Common Stock on June 1, 2027, if he continues in service through that date. Following this award, he holds 9,761 shares of Common Stock directly.
KAWALEK POLLY B reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp director Polly B. Kawalek received a grant of 1,964 restricted stock units (RSUs) that will settle one-for-one in shares of Common Stock on June 1, 2027, subject to her continued service. Following this award, she directly holds 76,024 shares.
JACKSON LAWRENCE V reported acquisition or exercise transactions in this Form 4 filing.
JBT MAREL Corp director JACKSON LAWRENCE V received a grant of 1,232 restricted stock units (RSUs) of Common Stock. The award was recorded at a price of $0.00 per share as a compensation grant, not an open-market purchase or sale.
The RSUs will settle one-for-one into shares of Common Stock on June 1, 2027, provided the director continues in service through that date. After this award, the director holds 10,783 shares of Common Stock directly, giving context for the size of this routine compensation-related grant.
JBT MAREL Corp director Charles L. Harrington received a grant of 1,964 restricted stock units (RSUs). These RSUs will convert one-for-one into shares of common stock on June 1, 2027, provided he continues serving the company through that date.
After this award, Harrington directly holds 11,356 shares of JBT MAREL Corp common stock. The transaction reflects equity compensation rather than an open-market stock purchase or sale, aligning his incentives with long-term shareholder interests through time-based vesting.